ÀÚµ¿·Î±×¾Æ¿ô¾È³»
ÀÚµ¿ ·Î±×¾Æ¿ô ³²Àº ½Ã°£ : 30ÃÊ
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µË´Ï´Ù. ·Î±×ÀÎ ½Ã°£À» ¿¬ÀåÇϽðڽÀ´Ï´Ù?
ÀÚµ¿·Î±×¾Æ¿ô¾È³»
°í°´´ÔÀÇ ¾ÈÀüÇÑ Á¤º¸º¸¾ÈÀ» À§ÇØ ·Î±×ÀÎ ÈÄ ¾à10ºÐµ¿¾È ¼ºñ½º ÀÌ¿ëÀÌ ¾ø¾î ÀÚµ¿ ·Î±×¾Æ¿ô µÇ¾ú½À´Ï´Ù.
±¸ºÐ | ºÐ·ù | Ç׸ñ | °¡°ÝÁ¤º¸ (´ÜÀ§ : ¿ø) | ƯÀÌ»çÇ× | ÃÖÁ¾º¯°æÀÏ | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
¸íĪ | ÄÚµå | ±¸ºÐ | ºñ¿ë | ÃÖÀúºñ¿ë | ÃÖ´ëºñ¿ë | Ä¡·áÀç·á´ë Æ÷ÇÔ¿©ºÎ |
¾àÁ¦ºñ Æ÷ÇÔ¿©ºÎ |
||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | NGS À¯ÀüÀÚ ÆÐ³Î °Ë»ç(°ËÁø¿ë) | CB001 | 1,907,280 | 2020-11-27 | ||||||
ÃÊÀ½ÆÄ | µÎ°æºÎ | NS ³úÇ÷°ü ÃÊÀ½ÆÄ(ÃßÀû°Ë»ç1ȸ) | EB481 | 184,600 | 2018-10-01 | ||||||
óġ¹× ¼ö¼ú·á | ÇǺΠ¹× ¿¬ºÎÁ¶Á÷ | Nd-YAG »ö¼Ò·¹ÀÌÀú A | NPIS0003 | 171,700 | 2017-01-01 | ||||||
óġ¹× ¼ö¼ú·á | ÇǺΠ¹× ¿¬ºÎÁ¶Á÷ | Nd-YAG »ö¼Ò·¹ÀÌÀú B | NPIS0003 | 343,400 | 2017-01-01 | ||||||
óġ¹× ¼ö¼ú·á | ÇǺΠ¹× ¿¬ºÎÁ¶Á÷ | Nd-YAG »ö¼Ò·¹ÀÌÀú C | NPIS0003 | 629,600 | 2017-01-01 | ||||||
óġ¹× ¼ö¼ú·á | ÇǺΠ¹× ¿¬ºÎÁ¶Á÷ | Nd-YAG »ö¼Ò·¹ÀÌÀú D | NPIS0003 | 795,000 | 2017-01-01 | ||||||
óġ¹× ¼ö¼ú·á | ÇǺΠ¹× ¿¬ºÎÁ¶Á÷ | Nd-YAG »ö¼Ò·¹ÀÌÀú [±âº»] | NPIS0003 | 10,600 | 2017-01-01 | ||||||
ÃÊÀ½ÆÄ | µÎ°æºÎ | Neck Biopsy gun1 -Special Guiding SONO For Procedure(¥±) | EB562 | 167,000 | 2019-05-03 | ||||||
ÃÊÀ½ÆÄ | µÎ°æºÎ | Neck Biopsy gun2 -Special Guiding SONO For Procedure(¥±) | EB562 | 217,000 | 2019-05-03 | ||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | Neurofibromatosis, type 1 | CZ629 | 1,327,700 | 2017-01-01 | ||||||
°Ë»ç·á | ºÐÀÚº´¸®°Ë»ç | Noonan syndrom(PTPN11gene mutation) | CZ621 | 525,140 | 2017-01-01 | ||||||
óġ¹× ¼ö¼ú·á | ±âŸ | OIT °ü¸®·á | QZ965 | 20,000 | 2024-02-14 | ||||||
óġ¹× ¼ö¼ú·á | ±âŸ | OIT ÃʱⱳÀ°ºñ | QZ965 | 70,000 | 2024-07-11 | ||||||
óġ¹× ¼ö¼ú·á | Ä¡·áÀç·á | OXIRIS SET | AAF09130 | 1,512,500 | 2025-01-14 | ||||||
°Ë»ç·á | ¼¼Æ÷¸é¿ª°Ë»ç | Oligomerized amyloid-beta (¿Ã¸®°í¸ÓÈ ¾Æ¹Ð·ÎÀÌµå º£Å¸) | CZ117 | 110,000 | 2023-06-01 |